ForHumanity

We expect to have information over the next two months... in the mean time, if you care to, please like the Facebook page so we can establish an effective communication channel.

Thanks to everyone again, especially Exabrial for posting my article here. If anyone has any questions, please post them and I will address them or ask Dr. Rider for a response.

I was hoping someone might be able to point me to another site where I could post my article that would result in as many eyes coming for a look.

As to Tokenadult's comment... the article isn't a plea for funding, it is an attempt to get DRACO into the public's mind. However, myself and a few others have come together to search for a way to fund Dr. Rider's work. So, this post, is a plea for funding. We will have a site up soon as we have found a way to fund his research. We have no desire for financial reward for ourselves, we simply want the full potential of his work explored... rapidly.

I would like to thank you all for reading my article. I have spent most of my life thus far in technology, coding since I was 10. This was back when the TI99/4a was news and 32k was alot of elbo room.

About 14 years ago I decided to study Neuroscience so I could build a better human/computer interface. Little did I know that I was igniting a latent passion for the biosciences that would consume my free time hence forth and thousands of dollars.

I related quickly to the biosciences because molecular physiology bears a striking semblance to computer/software architecture.

Now, I have had an article published on my proposed targeted cancer therapeutic (http://blog.readingthinkingandwriting.com/?p=411) and I have turned my focus to Dr. Rider's work at MIT to end viral infections of all types.

http://blog.readingthinkingandwriting.com/?p=500

The expectations of Dr. Rider with regard to targets of DRACO include HIV, and I would ask that anyone who reads my article pays close attention. I have attempted to relay the science behind the reason I have concluded that Dr. Rider's work will be historic. And I hope I have done just that, though I apologize for where I've failed.

Tissue penetration is addressed by the mouse models... and, from the way our immune system operates. Where an infection resides, molecules are spread that increase vascular permeability and constrict draining vessles thus concentrating blood volume. This is essentially how any medicine acts with specifitcity to the location of infection and what assures DRACO will hit target cells.

Further research in Dr. Rider's lab has shown that not only does DRACO succesfully induce the destruction of infected cells, but that it also reduces the viral titres (quantity of the virus).

I'm happy to answer any further questions.